Abstract
Autosomal recessive polycystic kidney disease (ARPKD) is characterized by the development of renal cysts of tubular epithelial cell origin. Dysfunction and aberrant regulation of the epithelial Na+ channel (ENaC) lead to a spectrum of diseases ranging from hyper‐and hypotension associated with improper renal Na+ conservation and wasting, respectively, to cystic fibrosis. Members of the epidermal growth factor (EGF) family have direct actions on Na+ reabsorption in the distal nephron. It has also been reported that EGF receptor (EGFR) is overexpressed and mislocalized to the apical membranes in the cystic epithelia. Here we tested whether ENaC plays a role in the cyst development in PCK rats, model of ARPKD. 4 and 12 weeks treatment with ENaC inhibitor benzamil caused more severe cyst formation in PCK rats. Patch clamp studies of ENaC in freshly isolated cysts and immunohistochemical analysis confirm that ENaC expression and activity are modulated in the freshly isolated cysts of PCK compared to benzamil‐treated and noncystic collecting duct. We conclude that abnormal EGF signaling leads to inappropriately low ENaC activity which contributes to cyst formation in PCK rats. Thus, the disruption of the EGF‐EGFR axis reported in PKD is linked to suppression of normal Na+ reabsorption and further progress of this kidney disease. Supported by the AHA 10POST4140109; ADA 1–10‐BS‐168; NIH HL108880.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
